» Articles » PMID: 8790413

A Candidate Live Inactivatable Attenuated Vaccine for AIDS

Overview
Specialty Science
Date 1996 Sep 3
PMID 8790413
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The recent discovery of long term AIDS nonprogressors who harbor nef-attenuated HIV suggests that a naturally occurring live vaccine for AIDS may already exist. Animal models have shown that a live vaccine for AIDS, attenuated in nef, is the best candidate vaccine. There are considerable risks, real and perceived, with the use of live HIV vaccines. We have introduced a conditional lethal genetic element into HIV-1 and simian immunodeficiency virus (SIV) molecular clones deleted in nef. The antiviral strategy we employed targets both virus replication and the survival of the infected cell. The suicide gene, herpes simplex virus thymidine kinase (tk), was expressed and maintained in HIV over long periods of time. Herpes simplex virus tk confers sensitivity to the antiviral activity of acyclic nucleosides such as ganciclovir (GCV). HIV-tk and SIV-tk replication were sensitive to GCV at subtoxic concentrations, and virus-infected cells were eliminated from tumor cell lines as well as primary cell cultures. We found the HIV-tk virus to be remarkably stable even after being cultured in media containing a low concentration of GCV and then challenged with the higher dose and that while GCV resistant escape mutants did arise, a significant fraction of the virus remained sensitive to GCV.

Citing Articles

Radiolabeled antiviral drugs and antibodies as virus-specific imaging probes.

Bray M, Di Mascio M, Kok-Mercado F, Mollura D, Jagoda E Antiviral Res. 2010; 88(2):129-142.

PMID: 20709111 PMC: 7125728. DOI: 10.1016/j.antiviral.2010.08.005.


AIDS vaccine development: let a thousand flowers bloom.

Oxford J, Addawe M, Lambkin R J Clin Pathol. 1999; 51(10):725-30.

PMID: 10023333 PMC: 500925. DOI: 10.1136/jcp.51.10.725.


Regulation of human immunodeficiency virus replication by 2',5'-oligoadenylate-dependent RNase L.

Maitra R, Silverman R J Virol. 1998; 72(2):1146-52.

PMID: 9445011 PMC: 124589. DOI: 10.1128/JVI.72.2.1146-1152.1998.

References
1.
Kirchhoff F, Greenough T, Brettler D, Sullivan J, Desrosiers R . Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med. 1995; 332(4):228-32. DOI: 10.1056/NEJM199501263320405. View

2.
Sullivan V, Talarico C, STANAT S, Davis M, Coen D, Biron K . A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature. 1992; 358(6382):162-4. DOI: 10.1038/358162a0. View

3.
Bryson Y, Pang S, Wei L, Dickover R, Diagne A, Chen I . Clearance of HIV infection in a perinatally infected infant. N Engl J Med. 1995; 332(13):833-8. DOI: 10.1056/NEJM199503303321301. View

4.
Chou S, Erice A, Jordan M, Vercellotti G, Michels K, Talarico C . Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis. 1995; 171(3):576-83. DOI: 10.1093/infdis/171.3.576. View

5.
Gibbs J, Lackner A, Lang S, Simon M, Sehgal P, Daniel M . Progression to AIDS in the absence of a gene for vpr or vpx. J Virol. 1995; 69(4):2378-83. PMC: 188910. DOI: 10.1128/JVI.69.4.2378-2383.1995. View